等待开盘 10-18 09:30:00 美东时间
-1.670
-1.33%
Needham analyst Gil Blum has maintained their bullish stance on SRPT stock, giv...
10-14 18:35
Capricor Therapeutics (NASDAQ:CAPR) stock rose 5% in midday trading Friday after the company reported positive long-term data from a study of its drug deramiocel in the treatment of Duchenne muscular ...
10-12 00:41
Capricor Therapeutics (NASDAQ:CAPR) stock rallied 20% Friday afternoon following news the company plans to present long-term data from its HOPE-2 open-label extension study of its lead drug deramiocel...
10-05 01:33
In the ever-changing and fiercely competitive business landscape, conducting th...
10-03 23:00
RBC Capital analyst Brian Abrahams reiterates Sarepta Therapeutics (NASDAQ:SRPT) with a Outperform and maintains $181 price target.
09-19 22:23
This whale alert can help traders discover the next big trading opportunities. ...
09-19 01:35
The latest update is out from Sarepta Therapeutics ( ($SRPT) ). Sarepta Therape...
09-16 21:17
Ratings for Sarepta Therapeutics (NASDAQ:SRPT) were provided by 26 analysts in ...
09-07 01:01
Shares of Dyne Therapeutics (NASDAQ:DYN) fell 31% Tuesday after the company released new data from a clinical trial called DELIVER for its drug DYNE-251 in the treatment of Duchenne muscular dystrophy...
09-04 04:48
新浪财经ESG评级中心提供包括资讯、报告、培训、咨询等在内的14项ESG服务,助力上市公司传播ESG理念,提升ESG可持续发展表现。点击查看【 ESG评级中...
08-28 07:01